blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2192132

EP2192132 - Anti-IL-20, anti-IL22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.08.2011
Database last updated on 31.08.2024
Most recent event   Tooltip12.08.2011Application deemed to be withdrawnpublished on 14.09.2011  [2011/37]
Applicant(s)For all designated states
ZymoGenetics, Inc.
1201 Eastlake Avenue East
Seattle, Washington 98102 / US
[2010/22]
Inventor(s)01 / Xu, Wenfeng
8809 25th Place NE
Seattle, WA 98115 / US
 [2010/22]
Representative(s)Griffin, Philippa Jane
Mathys & Squire The Shard
32 London Bridge Street
London SE1 9SG / GB
[N/P]
Former [2010/22]Griffin, Philippa Jane
Mathys & Squire LLP 120 Holborn London
EC1N 2SQ / GB
Application number, filing date10152572.308.02.2006
[2010/22]
Priority number, dateUS20050650830P08.02.2005         Original published format: US 650830 P
[2010/22]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2192132
Date:02.06.2010
Language:EN
[2010/22]
Type: A3 Search report 
No.:EP2192132
Date:18.08.2010
[2010/33]
Search report(s)(Supplementary) European search report - dispatched on:EP19.07.2010
ClassificationIPC:C07K16/28, C07K14/715
[2010/22]
CPC:
C07K16/244 (EP,US); A61P1/04 (EP); A61P17/00 (EP);
A61P17/06 (EP); A61P19/02 (EP); A61P29/00 (EP);
C07K14/7155 (EP,US); C07K16/2866 (EP,US); A61K2039/505 (EP,US);
A61K39/00 (EP,US); C07K2317/34 (EP,US); C07K2317/73 (EP,US);
C07K2317/76 (EP,US); C07K2317/92 (EP,US); C07K2319/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/22]
TitleGerman:Anti-il-20-, Anti-il-22- und Anti-il-22ra-Antikörper und Bindungspartner sowie Verwendungsverfahren bei Entzündungen[2010/22]
English:Anti-IL-20, anti-IL22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation[2010/22]
French:Anticorps et partenaires de liaison anti-il-20, anti-il-22 et anti-il-22ra, et methodes d'utilisation de ces anticorps et partenaires de liaison dans des processus inflammatoires[2010/22]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure03.02.2010Examination requested  [2010/22]
19.02.2011Application deemed to be withdrawn, date of legal effect  [2011/37]
29.04.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/37]
Parent application(s)   TooltipEP06734517.3  / EP1856156
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060734517) is  05.08.2009
Fees paidRenewal fee
03.02.2010Renewal fee patent year 03
03.02.2010Renewal fee patent year 04
03.02.2010Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
28.02.201106   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO0212345  (ZYMOGENETICS INC [US]);
 [X]WO2004085476  (ZYMOGENETICS INC [US], et al);
by applicantUS4331647
 US4486533
 EP0154316
 US4599311
 US4603044
 US4615974
 US4661454
 US4845075
 US4870008
 US4882279
 US4931373
 US4935349
 US4946778
 US4977092
 US4990446
 US5037743
 WO9111465
 US5063154
 WO9206204
 US5139936
 US5143830
 JPH04244018
 US5155027
 US5162228
 US5208146
 US5223409
 US5252714
 US5300435
 US5382657
 US5403484
 WO9521258
 US5567584
 US5571698
 EP0742830
 WO9717450
 WO9717451
 WO9720078
 US5637677
 US5641655
 US5693762
 WO9802536
 WO9802565
 US5716808
 US5723323
 US5723125
 US5736383
 US5738846
 US5747334
 US5750375
 US5783384
 WO9927103
 US5945511
 US5965704
 US6018026
 WO0024758
 WO0140467
 WO0146232
 WO0212345
 WO02068476
 WO02072607
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.